drugset / Trial / NCT03984604
Investigation of the Efficacy and Safety of CHI-921 in Insomnia.
Phase 2
Terminated
21 enrolled
Canopy Growth Corporation
Algorithme Pharma Inc · collabCentre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal · collabCentre hospitalier de l'Université de Montréal (CHUM) · collabGalenova Inc · collabMcGill University Health Centre/Research Institute of the McGill University Health Centre · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
Insomnia is a disorder where people are having trouble sleeping and can include difficulty falling asleep, staying asleep and waking up too early, as well as having unrefreshing sleep. CHI-921 is a cannabis extract in sunflower oil produced as a treatment for insomnia. This trial is designed to evaluate the efficacy and safety of CHI-921 on people with insomnia.
Timeline
- Start
- 2019-03-21
- Primary completion
- 2020-06-17
- Completion
- 2020-06-17
Outcome
Outcome not reported
Stopped: “COVID-19”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | CHI-921 | Unknown | 2 ml | Oral |